Propane

Propane

SCHEMBL28339028

CCC.O=S(=O)(O)CCO

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
BLM P54132 2/20 0.43
PTGS1 P23219 1/20 0.43
PDE4A P27815 1/20 0.43
SLC6A6 P31641 1/20 0.43
CYP2C19 P33261 1/20 0.43
APP P05067 1/20 0.39
POLB P06746 3/20 0.34
ALDH1A1 P00352 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 1/20 0.34
ALOX15 P16050 1/20 0.34
BRCA1 P38398 1/20 0.34
HTT P42858 1/20 0.34
GMNN O75496 1/20 0.34
PKM P14618 1/20 0.34
THPO P40225 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL970746 0.94 LMNA (0.43) LMNABLMPTGS1PDE4ASLC6A6
Alcohol SCHEMBL490837 0.94 LMNA (0.43) LMNABLMPTGS1PDE4ASLC6A6
Methyl Alcohol SCHEMBL28253720 0.90
SCHEMBL827 0.90
SCHEMBL249947 0.90 LMNA (0.50) LMNABLMPTGS1PDE4ASLC6A6
SCHEMBL28031140 0.88 LMNA (0.39) LMNABLMPTGS1PDE4ASLC6A6
SCHEMBL18155126 0.88 LMNA (0.43) LMNABLMPTGS1PDE4ASLC6A6
SCHEMBL19814012 0.88
SCHEMBL1138826 0.87
SCHEMBL1304651 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114044800-A Aryl, heteroaryl and heterocyclic compounds for the treatment of medical disorders 艾其林医药公司 2022-02-15 CN disclosed
CN-112839945-A Morphic forms of complement factor D inhibitors 艾其林医药公司 2021-05-25 CN disclosed
CN-112250673-A Aryl, heteroaryl and heterocyclic compounds for the treatment of complement mediated diseases 艾其林医药公司 2021-01-22 CN disclosed
CN-106456604-B Aryl, heteroaryl and heterocyclic compounds for the treatment of complement mediated diseases 艾其林医药公司 2020-11-06 CN disclosed
CN-111437278-A Aryl, heteroaryl and heterocyclic compounds for the treatment of complement mediated diseases 艾其林医药公司 2020-07-24 CN disclosed
CN-110603252-A Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders 艾其林医药公司 2019-12-20 CN disclosed